Skip to content

Subscriptions are live.

Plans

Why is $ACOG stock moving today?

Alpha Cognition Inc. Common Stock · Biological Products, (No Diagnostic Substances)

Why is $ACOG moving today?

The likely driver

Alpha Cognition Inc.: Q2 FY2026 results, three months to Jun 30, 2025
Alpha Cognition Inc.: Q2 FY2026 results, three months to Jun 30, 2025
SEC filing · Aug 13
Price
$8.31
Move today
+0.0%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
19
Market cap
$181M
Prev close
$8.31
Avg volume
122K

Nothing has triggered on ACOG yet in this session. Our scanner has flagged it 19 times in the last 30 days , most recently on October 22 for big percentage moves, unusual volume, which is why this page is here. See the full ACOG page for the chart and the alert history.

Earlier scanner activity on ACOG

  • Oct 22Unusual volume (RVOL) alert
  • Oct 21Unusual volume (RVOL) alert
  • Oct 15Big % mover alert
  • Oct 15Unusual volume (RVOL) alert
  • Oct 15Big % mover alert
  • Oct 13Big % mover alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 13Big % mover alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 12Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $ACOG alerts the moment volume spikes

Our scanner flagged $ACOG 19 times in the last 30 days. Create a free account to track $ACOG, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.